Aneurysmal Disease Clinical Trials
2 recruiting trials for Aneurysmal Disease. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Aneurysmal Disease clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Kolding Sygehus (1), The Cleveland Clinic (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Transverse groin incision (procedure, 1 trial), followed by Longitudinal incision.
Track Aneurysmal Disease trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Transverse Versus Longitudinal Groin Incision in Vascular Surgery
The purpose of the study is to examine whether incision type has an influence on the development of groin wound complications after operation in the groin in vascular surgery....
Vascular Lab Resource (VLR) Biorepository
This is a study of biomarkers obtained from prospectively collected subject samples and their correlation with cardiovascular and metabolic diseases. The purpose of this...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Aneurysmal Disease, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Aneurysmal Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Aneurysmal Disease, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.